Can on! Help Altria Capture More of the Booming Pouch Market?

02.09.25 16:51 Uhr

Werte in diesem Artikel
Aktien

55,71 EUR -0,31 EUR -0,55%

Indizes

PKT PKT

18.081,7 PKT 100,0 PKT 0,56%

3.342,0 PKT -3,5 PKT -0,11%

6.715,8 PKT 0,4 PKT 0,01%

Altria Group, Inc. (MO) is sharpening focus on the booming nicotine pouch category and its on! brand is leading the charge. In the second quarter of 2025, shipments rose 26.5% year over year to 52.1 million cans, lifting on!’s retail share of the U.S. oral tobacco market to 8.7%. The U.S. nicotine pouch category itself grew 52% of the total U.S. oral tobacco category, reflecting a rapid shift in consumer preferences. Within this segment, on! captured 16.7% share in the second quarter and 17.3% in the first half, underscoring its growing momentum.Altria has leaned heavily into brand-building to capture this momentum. Through event activations at NASCAR races, music festivals and premier golf tournaments, along with a digital campaign generating 190 million impressions, on! reached more than 170,000 adult tobacco consumers in the first half of 2025. These efforts lifted brand awareness by 7 percentage points, signaling growing traction.Beyond shipment gains, on!’s strength showed up in earnings. The oral tobacco segment delivered a 10.9% increase in adjusted operating companies income (“OCI”) year over year, with margins expanding to 68.7% from 65.6% in the prior-year quarter.Still, competition in the pouch category is intensifying, with rivals pressing hard to capture share. The key question is whether Altria’s combination of scale, marketing strength and retail reach can sustain the brand’s momentum. If on! maintains the current pace of growth, it could become one of the company’s most important offsets to declining cigarette volumes.Altria Competes With PM and TPB in PouchesPhilip Morris International Inc. (PM) continues to strengthen its U.S. and global nicotine pouch position through ZYN, which saw U.S. offtake growth of 26% in the second quarter of 2025. Globally, Philip Morris’ ZYN volumes surged 43%, supported by expansion into 44 markets. Philip Morris’ multi-category smoke-free strategy, which includes IQOS and VEEV, underpins double-digit smoke-free revenue growth, helping offset declines in combustible products and reinforcing ZYN’s role as a long-term growth engine in the oral tobacco category.Turning Point Brands, Inc. (TPB) is rapidly scaling in the white nicotine pouch category, Modern Oral sales up nearly eightfold year over year to $30.1 million in the second quarter of 2025. Aided by a growing sales force and expanded chain distribution, Turning Point Brands' FRE and ALP are gaining traction through both direct-to-consumer and retail channels. This momentum underscores Turning Point Brands’ emergence as a fast-growing challenger to larger players in the evolving oral nicotine market.MO’s Price Performance, Valuation & EstimatesShares of Altria have gained 8.5% in the past month compared with the industry’s growth of 3.9%.Image Source: Zacks Investment ResearchFrom a valuation standpoint, MO trades at a forward price-to-earnings ratio of 12.2X, down from the industry’s average of 15.35X.Image Source: Zacks Investment ResearchThe Zacks Consensus Estimate for MO’s 2025 and 2026 earnings per share has inched up a cent each in the past 30 days to $5.39 and $5.55, respectively.Image Source: Zacks Investment ResearchAltria currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They includeStock #1: A Disruptive Force with Notable Growth and ResilienceStock #2: Bullish Signs Signaling to Buy the DipStock #3: One of the Most Compelling Investments in the MarketStock #4: Leader In a Red-Hot Industry Poised for GrowthStock #5: Modern Omni-Channel Platform Coiled to SpringMost of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.Download Atomic Opportunity: Nuclear Energy's Comeback free today.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Altria Group, Inc. (MO): Free Stock Analysis Report Philip Morris International Inc. (PM): Free Stock Analysis Report Turning Point Brands, Inc. (TPB): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Altria und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Altria

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Altria

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Altria Inc.

Wer­bung

Analysen zu Altria Inc.

DatumRatingAnalyst
02.04.2020Altria HoldJefferies & Company Inc.
12.07.2019Altria buyGoldman Sachs Group Inc.
31.07.2017Altria NeutralUBS AG
31.07.2017Altria BuyStifel, Nicolaus & Co., Inc.
31.07.2017Altria Sector PerformRBC Capital Markets
DatumRatingAnalyst
12.07.2019Altria buyGoldman Sachs Group Inc.
31.07.2017Altria BuyStifel, Nicolaus & Co., Inc.
27.06.2016Altria Group BuyStifel, Nicolaus & Co., Inc.
02.02.2015Altria Group BuyStifel, Nicolaus & Co., Inc.
31.10.2014Altria Group BuyStifel, Nicolaus & Co., Inc.
DatumRatingAnalyst
02.04.2020Altria HoldJefferies & Company Inc.
31.07.2017Altria NeutralUBS AG
31.07.2017Altria Sector PerformRBC Capital Markets
09.08.2012Altria Group neutralCitigroup Corp.
26.07.2012Altria Group neutralUBS AG
DatumRatingAnalyst
23.03.2017Altria Group UnderperformRBC Capital Markets
27.04.2005Update UST Inc.: UnderperformGoldman Sachs
27.04.2005UST: UnderweightJP Morgan
24.01.2005UST: UnderweightJP Morgan

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Altria Inc. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen